Drugs / AMG 579
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01568203 | Sep 2011 → Jun 2012 | schizophrenia | Amgen | Terminated | No outcome recorded Stop: Business |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AMG 579 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01568203 ↗ |
| Route | Oral | “single oral dose administration of AMG 579” NCT01568203 ↗ |